Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denileukin diftitox in previously treated follicular low-grade Non-Hodgkin's Lymphoma
NCT00003615Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- May 1999
- Primary completion
- Aug 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of denileukin diftitox in non-Hodgkin lymphoma (NHL), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Objective Response Rate. Started May 1999; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003615.